StockData
MBody AI Ltd. logo

MBody AI Ltd. (MBAI) company profile

MBAINasdaqServices-Computer Integrated Systems Design
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 27, 2026Score 5/30
$2.05−0.03 (-1.44%)

Close on Nov 17, 2026Market cap $14.39MP/E 3.1Yield –

About MBody AI

Services-Computer Integrated Systems Design, SIC 7373

Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on developing screening technologies for the gastrointestinal tract. Its primary product candidate is C-Scan, an ingestible capsule system comprising the C-Scan Cap, C-Scan Track, and C-Scan View. The system uses imaging alongside an oral contrast agent to detect colorectal abnormalities. Check-Cap designs its diagnostic solutions for patients requiring gastrointestinal screening, alongside physicians and clinical healthcare providers.

The enterprise operates from principal executive offices, research and development facilities, and manufacturing sites located in Isfiya, Mount Carmel, Israel. Geographically, Check-Cap focuses its clinical development and commercial distribution across Israel, the United States, Europe, and Japan. In addition to its core operations, the company holds franchise rights in New Jersey. Check-Cap relies on centralized facilities and third-party relationships to support its clinical and operational footprint.

Summary of the business section of MBody AI's latest annual report, written by StockData.

Company profile

Company

Legal name
MBody AI Ltd.
Headquarters
Isfiya, Israel
Address
Abba Hushi Avenue, P.O. Box 1271 000000
Phone
972-4-8303400
Website
mbody.ai
Employees
8,289, Dec 31, 2024
Industry
Services-Computer Integrated Systems Design
Incorporated in
L3
Auditor
BCRG Group, Irvine, CA

Stock & identifiers

Ticker
MBAI
Former tickers
CHEK until Apr 27, 2026
Exchange
Nasdaq
IPO date
Feb 20, 2015
Shares outstanding
7M, Dec 31, 2025
Filer category
Non-accelerated filer
Stock splits
1-for-7 reverse, Aug 13, 2026; 1-for-19.67 reverse, Mar 31, 2023; 1-for-20 reverse, Nov 25, 2022; 1-for-12 reverse, Apr 4, 2018
SEC CIK
1610590
CUSIP
M6S83C106
FIGI
BBG0089RJVS4
Share class FIGI
BBG0089RJWL9
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
John Alexander FowlerChief Executive Officer, Director670,064
Timothy John HaydenChief Financial Officer79,717
Alan D. LewisCFO–
Kai Michael Toft SorensenDirector4,028
Masri Ghaleb ElDirector–
Scott Robertson WaltersDirector79,717
Regan McMillan McGeeDirector6,860,097
Anurag Dilip SharmaDirector–
David LontiniDirector–
Carlos CheungDirector–
Daniel KokiwDirector–
Michael HuttonDirector–

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Feb 20, 2015
Offer price
$6.00
Securities offered
2,000,000
Gross proceeds
$12.00M
Exchange
Nasdaq
First trading day
Mar 4, 2015
First-day close
$6.08+1.3%
Lock-up ends (est.)
Aug 31, 2015

“The initial public offering price is $6.00 per unit.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“The CRC-PREVENT trial included 8,289 individuals with diverse racial, ethnic, and socioeconomic backgrounds across more than 2,900 zip codes in all lower 48 states, with colonoscopies performed in more than 3,800 endoscopy centers.”

Corporate history

Events identified from SEC filings

DateEventDetails
Aug 28, 2026Name changeName changed from Check-Cap Ltd to MBody AI Ltd.
May 1, 2025Late filingNotification of late filing
May 1, 2024Late filingNotification of late filing
May 1, 2023DelistingNotice of delisting from exchange (Form 25)
Feb 20, 2020DelistingNotice of delisting from exchange (Form 25)
May 3, 2018ListingRegistration of securities on an exchange (Form 8-A)
Feb 20, 2015IPOInitial public offering priced (424B4 prospectus)
Feb 11, 2015ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?